Target intelligence / Profile preview

Viral attachment to host cell

Molecular classification
Other
01

Overview

"Viral attachment to host cell" describes the initial step in viral infection where specific proteins or glycans on the virus bind to particular receptors, adhesion molecules, or glycans on the host cell surface[1][2][3][5]. This process mediates host specificity, cell tropism, and is a prerequisite for viral entry, which can proceed via direct membrane fusion, endocytosis, or other mechanisms depending on the virus[3][5]. Attachment is mediated by viral proteins (such as the spike protein in SARS-CoV-2 or the glycoprotein in HIV) that recognize and bind host molecules including sialylated glycans, integrins, immunoglobulin superfamily members, and others[2][3][4]. Therapies targeting viral attachment aim to prevent the virus from binding to its host entry receptor, thus blocking infection at its earliest stage[3][4][5].

Other names
Viral attachmentVirus–receptor interactionVirus binding to host cellViral bindingVirus–host cell attachment
02

Mechanism of action

Blockade of virus binding to host receptor (antibodies or receptor mimics); Inhibition of membrane fusion (fusion inhibitors); Competitive inhibition of receptor binding (decoy receptors or small molecules)

03

Biological functions

Virus entryHost recognitionInitiation of infectionCellular signaling (triggered by virus–receptor interaction)
04

Disease associations

InfectionCan contribute indirectly to inflammation, immune response, and pathogenesis depending on virus
05

Safety considerations

Off-target effects due to interference with normal host cell adhesion molecules or receptorsImmune reactions to biologic drugs (antibodies, fusion proteins)Potential for viral escape by mutation of surface proteins
06

Interacting drugs

Monoclonal antibodies targeting viral entry proteins (e.g., SARS-CoV-2 spike protein)

3 more in the full profile.

07

Biomarkers

Level of viral attachment protein (e.g., spike protein for SARS-CoV-2)Host cell receptor expression (e.g., ACE2 for coronaviruses)Viral loadAntibody titers against viral entry proteins

Beyond the preview

Go deeper on Viral attachment to host cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral attachment to host cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call